SB-728

· Sangamo Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-728, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV [Phase 1]